Reps. Scott Peters, Bobby L. Rush and George Holding introduced a bipartisan bill this week that would increase patient access to key diagnostic radiopharmaceuticals used to help treat Alzheimer’s disease, Parkinson’s disease and numerous cancers.
The American College of Radiology (ACR) has issued a statement sharing “serious concerns” with HR 3630, the No Surprises Act, which is currently scheduled to be considered by the House Energy and Commerce Committee.
The American Society of Radiologic Technologists (ASRT) Board of Directors has announced that more research is required before it feels comfortable recommending the discontinuation of patient gonadal and fetal shielding during x-rays.
According to a new study published in JAMA Internal Medicine, providers should consider only discussing supplemental imaging with women with dense breasts if the patients are specifically at a higher risk for breast cancer.
A representative from the Medical Imaging & Technology Alliance (MITA) spoke at a public hearing organized by the Department of Health and Human Services, sharing insight into how patients can gain better access to key technologies.
DenseBreast-info, Inc. (DB-I) has shared its public comments on the FDA’s proposed changes to the Mammography Quality Standards Act of 1992 (MQSA). The FDA first announced its efforts to amend the MQSA back in March.
Financial conflicts of interest (FCOIs) do not appear to impact or influence the development of consensus breast cancer screening recommendations, according to a new study published in the Journal of the American College of Radiology.
The U.S. Pharmacopeia (USP) has published a new chapter on the minimum standards required to prepare, compound, dispense and repackage both sterile and non-sterile radiopharmaceuticals associated with state-licensed activities.